Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ABT
ABT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ABT News
Abbott Laboratories: A Steady Dividend Growth King
3d ago
Fool
Exact Sciences' Sale to Abbott Clears HSR Waiting Period
Feb 06 2026
seekingalpha
Abbott Unveils New Data on Atrial Fibrillation Treatments
Feb 06 2026
PRnewswire
AbbVie's Outlook: February Decline Appears to Indicate a Buying Opportunity
Feb 05 2026
Marketbeat
FDA Classifies Abbott's Product Recall as Most Serious After Deaths
Feb 04 2026
seekingalpha
FDA Reports 860 Serious Injuries and 7 Deaths Linked to Freestyle Libre 3 Sensors Recall by Abbott as of January 7
Feb 04 2026
moomoo
Healthcare Stocks Show Dividend Growth Potential
Feb 03 2026
Fool
AbbVie and Medtronic's Dividend Growth Potential
Feb 03 2026
NASDAQ.COM
Abbott Laboratories Reports Disappointing Q4 Results, Shares Decline
Feb 02 2026
Fool
Three Dividend Kings Worth Buying
Feb 01 2026
Fool
Investment Opportunities in Dividend Kings
Feb 01 2026
NASDAQ.COM
Abbott's Stock Drops Following Earnings Report as CEO Purchases $2 Million in Shares.
Jan 28 2026
Barron's
Abbott Shares Snap Six-Day Losing Streak with 1.2% Gain
Jan 26 2026
seekingalpha
Abbott CEO Robert Ford Acquires $2M in Company Stock
Jan 26 2026
seekingalpha
Abbott Laboratories Q4 2025 Results and Future Outlook
Jan 26 2026
Fool
Abbott Reports Disappointing Q4 Revenue, Stock Plummets
Jan 26 2026
NASDAQ.COM
Show More News
